This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Pavisse™ Incident Management System Receives Patent Pending Status

SAN FRANCISCO, May 7, 2014 /PRNewswire/ -- RGP Healthcare™, a division of Resources Global Professionals (NASDAQ: RECN), today announced that Pavisse™ has received Patent Pending Status from the U.S. Patent and Trademark Office.

Pavisse is a fully integrated incident management system that assists clients with the identification and prevention of errors through effective management of their patient safety program, HIPAA corporate, and payor compliance. Pavisse components include root cause analysis, claims management, physician peer review, and organizational compliance, along with management of the complaint and grievance process. In addition, Pavisse™ Audits provide a surveying method for monitoring processes to identify opportunities for improvement and recognition of best practices. 

Workflow driven and content rich, Pavisse is easily applied to any type of incident management workflow. Powerful enterprise reporting capabilities provide real-time dashboard views, as well as unparalleled internal benchmarking and graphing for easy-to-understand outcomes and identification of opportunities for improvement. Built around nationally recognized patient safety standards, Pavisse allows for streamlined reporting to Patient Safety Organizations and state level agencies.

A wide range of expert professional consulting and project management services are also available to help clients achieve their operational, clinical, and financial goals.

Pavisse has already been deployed at a number of hospitals, including IHHI, a four hospital healthcare system in the Los Angeles, California, area; and East Jefferson General Hospital in Metairie, Louisiana.

"We are delighted that Pavisse has received Patent Pending Status," said RGP Healthcare President Radgia Cook. "It is a great step toward remaining the most comprehensive incident reporting and management system for all healthcare organizations."

About RGP HealthcareHeadquartered in San Francisco, RGP Healthcare, the healthcare division of Resources Global Professionals, was created to meet the growing needs of the healthcare sector. Its consultants have deep industry knowledge and experience in a variety of disciplines, particularly patient safety, incident management, and remediation. Other specialty areas include sentinel event analysis, management of hospital readmissions, regulatory and HIPAA compliance, ICD-10 education, revenue cycle management, and other professional services that support and enhance the strategic initiatives of healthcare organizations of any type, including acute and long-term care providers.

About RGPRGP, the operating subsidiary of Resources Connection, Inc. (NASDAQ: RECN), is a multinational professional services firm that helps business leaders execute internal initiatives. Partnering with business leaders, we drive internal change across all parts of a global enterprise - accounting, finance, risk management and internal audit, corporate advisory, strategic communications and restructuring, information management, human capital, supply chain management, healthcare solutions, and legal and regulatory services.

RGP was founded in 1996 within a Big Four accounting firm. Today, we are a publicly traded company with 3,000 professionals, annually serving over 1,800 clients around the world from more than 70 practice offices.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs